ATE409465T1 - Parenteral verabreichbare mikropartikel- zubereitung mit kontrollierter freisetzung - Google Patents
Parenteral verabreichbare mikropartikel- zubereitung mit kontrollierter freisetzungInfo
- Publication number
- ATE409465T1 ATE409465T1 AT01975100T AT01975100T ATE409465T1 AT E409465 T1 ATE409465 T1 AT E409465T1 AT 01975100 T AT01975100 T AT 01975100T AT 01975100 T AT01975100 T AT 01975100T AT E409465 T1 ATE409465 T1 AT E409465T1
- Authority
- AT
- Austria
- Prior art keywords
- controlled release
- microparticle preparation
- parenterally administered
- curve
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0003614A SE517610C2 (sv) | 2000-10-06 | 2000-10-06 | Mikropartikelberedning |
US26049501P | 2001-01-08 | 2001-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE409465T1 true ATE409465T1 (de) | 2008-10-15 |
Family
ID=26655254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01975100T ATE409465T1 (de) | 2000-10-06 | 2001-10-05 | Parenteral verabreichbare mikropartikel- zubereitung mit kontrollierter freisetzung |
Country Status (8)
Country | Link |
---|---|
US (1) | US7033609B2 (de) |
EP (1) | EP1328258B1 (de) |
JP (1) | JP2004510730A (de) |
AT (1) | ATE409465T1 (de) |
AU (1) | AU2001294459A1 (de) |
CA (1) | CA2424896A1 (de) |
DE (1) | DE60136002D1 (de) |
WO (1) | WO2002028375A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6956021B1 (en) * | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US8017152B2 (en) | 2005-05-27 | 2011-09-13 | Stratosphere Pharma Ab | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
EP1726299A3 (de) * | 2005-05-27 | 2007-04-18 | StratoSphere Pharma AB | Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung |
BRPI0811777A2 (pt) * | 2007-05-23 | 2019-09-24 | Allergan Inc | partículas de ácido hialurõnico revestidas |
CA2687990A1 (en) * | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Cross-linked collagen and uses thereof |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
US8114898B2 (en) | 2007-11-16 | 2012-02-14 | Allergan, Inc. | Compositions and methods for treating purpura |
US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
ES2658609T3 (es) | 2008-09-02 | 2018-03-12 | Tautona Group Lp | Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos |
CN101574638B (zh) * | 2009-06-15 | 2012-04-18 | 中国农业大学 | 一种淀粉纳米微球及其制备方法 |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20130052647A1 (en) * | 2010-02-10 | 2013-02-28 | Marianna Goldrick | Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery |
CA2792729C (en) * | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
EP2550027B2 (de) | 2010-03-22 | 2019-03-20 | Allergan, Inc. | Vernetzte polysaccharid- und protein-polysaccharid-hydrogele für weichgewebeaugmentation |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
CN107412002A (zh) | 2011-06-03 | 2017-12-01 | 阿勒根公司 | 包括抗氧化剂的皮肤填充剂组合物 |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
EP3620184A1 (de) | 2014-09-30 | 2020-03-11 | Allergan Industrie, SAS | Stabile hydrogelzusammensetzungen mit additiven |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE744162A (fr) | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | Procede d'encapsulage |
US3881991A (en) | 1969-01-24 | 1975-05-06 | Hayashibara Co | Process for producing amylose powders having a mean degree of polymerization between 20{14 30 |
DE2010115A1 (de) | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
US4389330A (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4713249A (en) | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
EP0471036B2 (de) | 1989-05-04 | 2004-06-23 | Southern Research Institute | Einkapselungsverfahren |
DK168790D0 (de) | 1990-07-13 | 1990-07-13 | Novo Nordisk As | |
KR100259989B1 (ko) | 1991-10-01 | 2000-08-01 | 모리다 가쓰라 | 서방성 마이크로캡슐 제제 및 그의 제조법 |
WO1993015722A1 (en) | 1992-02-07 | 1993-08-19 | Syntex (Usa) Inc. | Controlled delivery of pharmaceuticals from preformed porous microparticles |
WO1993021008A1 (en) | 1992-04-20 | 1993-10-28 | Redding Bruce K Jr | Method and apparatus for the modification of starch and other polymers |
CA2150803C (en) | 1992-12-02 | 2006-01-31 | Henry Auer | Controlled release growth hormone containing microspheres |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
JPH08507806A (ja) | 1993-03-09 | 1996-08-20 | ミドルセツクス・サイエンシーズ・インコーポレーテツド | 高分子の微粒子および調製法 |
DE4434877A1 (de) | 1994-09-29 | 1996-04-04 | Fresenius Ag | Verfahren zur Herstellung von Stärkeabbauprodukten |
KR100201352B1 (ko) | 1995-03-16 | 1999-06-15 | 성재갑 | 단일주사 백신 제형 |
US5942253A (en) * | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
SE505146C2 (sv) * | 1995-10-19 | 1997-06-30 | Biogram Ab | Partiklar för fördröjd frisättning |
US5959102A (en) | 1997-06-30 | 1999-09-28 | Rutgers University | Starch purification by thermally tolerant broad pH range proteolytic enzymes |
SE512663C2 (sv) | 1997-10-23 | 2000-04-17 | Biogram Ab | Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer |
JPH11302156A (ja) | 1998-04-16 | 1999-11-02 | Tanabe Seiyaku Co Ltd | ポリペプチドの微粒子化方法 |
SE517422C2 (sv) * | 2000-10-06 | 2002-06-04 | Bioglan Ab | Farmaceutiskt acceptabel stärkelse |
-
2001
- 2001-10-05 EP EP01975100A patent/EP1328258B1/de not_active Expired - Lifetime
- 2001-10-05 AT AT01975100T patent/ATE409465T1/de not_active IP Right Cessation
- 2001-10-05 WO PCT/SE2001/002165 patent/WO2002028375A1/en active Application Filing
- 2001-10-05 AU AU2001294459A patent/AU2001294459A1/en not_active Abandoned
- 2001-10-05 CA CA002424896A patent/CA2424896A1/en not_active Abandoned
- 2001-10-05 DE DE60136002T patent/DE60136002D1/de not_active Expired - Fee Related
- 2001-10-05 JP JP2002532200A patent/JP2004510730A/ja active Pending
-
2002
- 2002-01-10 US US09/970,792 patent/US7033609B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1328258B1 (de) | 2008-10-01 |
AU2001294459A1 (en) | 2002-04-15 |
US7033609B2 (en) | 2006-04-25 |
JP2004510730A (ja) | 2004-04-08 |
US20020102311A1 (en) | 2002-08-01 |
DE60136002D1 (de) | 2008-11-13 |
CA2424896A1 (en) | 2002-04-11 |
WO2002028375A1 (en) | 2002-04-11 |
EP1328258A1 (de) | 2003-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE409465T1 (de) | Parenteral verabreichbare mikropartikel- zubereitung mit kontrollierter freisetzung | |
MY118835A (en) | Sustained release compositions and the process for their preparation | |
DE58909072D1 (en) | Alloplastisches implantat. | |
HU9501942D0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | |
DK0794790T3 (da) | Lokaliseret afgivelse af faktorer, der øger overlevelsen af transplanterede celler | |
CA2195119A1 (en) | Formulations and methods for providing prolonged local anesthesia | |
DK1137400T3 (da) | Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode | |
UA29563C2 (uk) | Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду | |
MY113488A (en) | Compounds with growth hormone releasing properties | |
IL153011A0 (en) | Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds | |
ATE266988T1 (de) | Kompresionsstrumpf oder -strumpfhose | |
IL115138A0 (en) | Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof | |
DE59909717D1 (de) | Verfahren zur Herstellung von festen Dosierungsformen | |
DK1152776T3 (da) | Bionedbrydelig, injicerbar oligomer-polymer-sammensætning | |
RS49608B (sr) | Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje | |
SE0003614D0 (sv) | Mikropartikelberedning | |
Magnin et al. | Hepatitis caused by micronized natural progesterone given for preterm labor | |
RU96109846A (ru) | Способ профилактики генерализации септической инфекции в раннем послеродовом периоде | |
WO2002018593A3 (en) | Modulation of fas and fasl expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |